#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hepatoblastoma Acute graft versus host disease in intestine Lymphoma Myelodysplastic syndrome with excess blasts Oropharyngeal squamous cell carcinoma Blood iron increased Lymphangioma Endometrial adenocarcinoma Erdheim-Chester disease Mucous membrane pemphigoid Heavy menstrual bleeding Neuroendocrine carcinoma metastatic Orthostatic hypotension Gastroenteropancreatic neuroendocrine tumour disease Activated PI3 kinase delta syndrome More trials…

    Learn about Rare Diseases

    VEXAS syndrome – Basic Information Von Willebrand’s disease – Treatment Biotinidase deficiency – Basic Information Pleomorphic leiomyosarcoma – Treatment Ewing’s sarcoma recurrent – Treatment Waldenstrom’s macroglobulinaemia refractory – Diagnostics Primary immunodeficiency syndrome – Trials in Disease Malignant fibrous histiocytoma Bronchopulmonary dysplasia – Treatment CADASIL – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Iptacopan Eprosartan Mesilate Abrocitinib Amcenestrant Pegaspargase HUPERZINE A Chloropyramine Hydrochloride Panitumumab Lithium Cobamamide XENON (133XE) Cebsulfase Alfa Paclitaxel Fingolimod Apremilast Benserazide Hydrochloride Glenzocimab Timothy Grass Pollen Extract Urea Cat Epithelium Extract More therapies…

    Learn about Your Condition

    Compulsive sexual behaviour Enteritis Hypochromic anaemia Cluster headache Hypothyroidism Cervix carcinoma stage II Bacterial prostatitis Arginase deficiency Influenza Stomatitis Breast cancer stage IV Neuromyopathy Procedural hypotension Aortic stenosis Anogenital warts More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Pathological Conditions, Signs and Symptoms

  • Study on Resuscitation in Early Septic Shock Using Sodium Chloride and a Drug Combination for Patients with Septic Shock

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Sodium Lactate
    • Calcium Chloride Dihydrate
    • Potassium Chloride
    Spain

  • Study on Fentanyl Nasal Spray and Morphine for Managing Postoperative Pain in Patients After Surgery

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Placebo
    • Fentanyl Citrate
    Bulgaria Germany

  • Study on the Safety and Tolerability of Oral Dersimelagon for Patients with Erythropoietic Protoporphyria or X-Linked Protoporphyria

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Dersimelagon Phosphate
    Bulgaria Czechia France Germany Italy The Netherlands +4

  • Study on Milrinone Infusion for Treating Vasospasm in Patients with Aneurysmal Subarachnoid Hemorrhage

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Aneurysm ruptured
    • Subarachnoid haemorrhage
    • Vasospasm
    Investigated Drugs:
    • Milrinone
    France

  • Study on the Effectiveness and Safety of Sparsentan and Dapagliflozin for Patients with Immunoglobulin A Nephropathy (IgAN)

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • IgA nephropathy
    Investigated Drugs:
    • Dapagliflozin
    • Irbesartan
    • Sparsentan
    Belgium Croatia Czechia Estonia France Germany +5

  • Study on the Effects of Selgantolimod and NUC Discontinuation in Patients with Chronic Hepatitis B

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Selgantolimod
    • Entecavir
    • Tenofovir Disoproxil
    France Germany Italy Spain
Previous Page
1 … 14 15 16 17 18 … 21
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!